Bayer brushed off some critics — and more than a few of its own shareholders — on Monday by offering to buy up Monsanto. The Germany-based Bayer — a pharmaceutical and agricultural chemical giant — is offering roughly $67 billion to buy up the St. Louis-based Monsanto — a company that's famous (or infamous) for its seeds and genetically modified crops.